HK1258374A1 - 止血組合物和使用止血組合物的止血方法 - Google Patents

止血組合物和使用止血組合物的止血方法

Info

Publication number
HK1258374A1
HK1258374A1 HK19100746.6A HK19100746A HK1258374A1 HK 1258374 A1 HK1258374 A1 HK 1258374A1 HK 19100746 A HK19100746 A HK 19100746A HK 1258374 A1 HK1258374 A1 HK 1258374A1
Authority
HK
Hong Kong
Prior art keywords
hemostatic
composition
hemostatic composition
hemostatic method
Prior art date
Application number
HK19100746.6A
Other languages
English (en)
Inventor
惠嗣 永野
小林　智
Original Assignee
立美基股份有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 立美基股份有限公司 filed Critical 立美基股份有限公司
Publication of HK1258374A1 publication Critical patent/HK1258374A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10—Peptides having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7015—Drug-containing film-forming compositions, e.g. spray-on
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
    • A61L26/0028—Polypeptides; Proteins; Degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
    • A61L26/0028—Polypeptides; Proteins; Degradation products thereof
    • A61L26/0047—Specific proteins or polypeptides not covered by groups A61L26/0033 - A61L26/0042
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061—Use of materials characterised by their function or physical properties
    • A61L26/0076—Sprayable compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00—Materials characterised by their function or physical properties
    • A61L2400/04—Materials for stopping bleeding

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Dispersion Chemistry (AREA)
  • Materials Engineering (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Dermatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Materials For Medical Uses (AREA)
  • Medicinal Preparation (AREA)
HK19100746.6A 2015-12-18 2019-01-16 止血組合物和使用止血組合物的止血方法 HK1258374A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2015247334 2015-12-18
PCT/JP2016/087298 WO2017104723A1 (ja) 2015-12-18 2016-12-14 止血用組成物、および、止血用組成物を用いた止血方法

Publications (1)

Publication Number Publication Date
HK1258374A1 true HK1258374A1 (zh) 2019-11-08

Family

ID=59056831

Family Applications (2)

Application Number Title Priority Date Filing Date
HK19100746.6A HK1258374A1 (zh) 2015-12-18 2019-01-16 止血組合物和使用止血組合物的止血方法
HK19100742.0A HK1258371A1 (zh) 2015-12-18 2019-01-16 止血組合物和使用止血組合物的止血方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
HK19100742.0A HK1258371A1 (zh) 2015-12-18 2019-01-16 止血組合物和使用止血組合物的止血方法

Country Status (11)

Country Link
US (2) US11298397B2 (zh)
EP (1) EP3391897B1 (zh)
JP (1) JP6951252B2 (zh)
KR (1) KR20180102583A (zh)
CN (1) CN108697755A (zh)
AU (1) AU2016374425B2 (zh)
BR (1) BR112018012260A2 (zh)
CA (1) CA3008589C (zh)
ES (1) ES2896726T3 (zh)
HK (2) HK1258374A1 (zh)
WO (1) WO2017104723A1 (zh)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7442196B2 (ja) 2018-07-03 2024-03-04 株式会社スリー・ディー・マトリックス イオン性自己組織化ペプチド
US20210220429A1 (en) * 2018-10-05 2021-07-22 Kurume University Pharmaceutical composition for treating or preventing ulcer or fistula in intestinal tract
EP4090350A1 (en) * 2020-01-13 2022-11-23 Arch Biosurgery, Inc. Self-assembling peptide gel formulation and methods of use
CN112023113B (zh) * 2020-08-29 2021-11-30 田卫群 一种HNTs/RG5纳米复合止血粉的制备方法及其应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3031466B1 (en) 2004-07-06 2018-11-28 3D Matrix, Inc. Purified amphiphilic peptide compositions and uses thereof
KR20100102750A (ko) 2005-04-25 2010-09-24 메사추세츠 인스티튜트 오브 테크놀로지 지혈 및 다른 생리학적 활성을 촉진하기 위한 조성물 및 방법
EP2146733B1 (en) 2007-03-14 2020-11-25 Arch Biosurgery, Inc. Treatment of leaky or damaged tight junctions and enhancing extracellular matrix
WO2010041636A1 (ja) * 2008-10-06 2010-04-15 株式会社スリー・ディー・マトリックス 組織閉塞剤
JP2015142720A (ja) * 2013-12-27 2015-08-06 株式会社メニコン 止血材
WO2015136370A2 (en) 2014-03-10 2015-09-17 3-D Matrix, Ltd. Sterilization and filtration of peptide compositions
TWI537022B (zh) 2015-04-28 2016-06-11 國立清華大學 閉迴路腦電刺激裝置及其刺激電壓的產生方法

Also Published As

Publication number Publication date
AU2016374425A1 (en) 2018-06-21
JPWO2017104723A1 (ja) 2018-10-04
US11298397B2 (en) 2022-04-12
ES2896726T3 (es) 2022-02-25
CA3008589C (en) 2024-01-23
US20180360904A1 (en) 2018-12-20
EP3391897B1 (en) 2021-09-08
CA3008589A1 (en) 2017-06-22
HK1258371A1 (zh) 2019-11-08
JP6951252B2 (ja) 2021-10-20
US20220265757A1 (en) 2022-08-25
BR112018012260A2 (pt) 2018-12-04
AU2016374425B2 (en) 2021-10-21
CN108697755A (zh) 2018-10-23
EP3391897A1 (en) 2018-10-24
KR20180102583A (ko) 2018-09-17
EP3391897A4 (en) 2019-08-14
WO2017104723A1 (ja) 2017-06-22

Similar Documents

Publication Publication Date Title
HK1257295A1 (zh) 用於免疫腫瘤學的組合物和方法
IL258288B (en) Hair strengthening compound and hair strengthening method
HK1259277A1 (zh) 結構複合材料和方法
GB2546350B (en) Compositions and methods
SG11202003790PA (en) Composition and method
GB201718876D0 (en) Antithrombin-heparin compositions and methods
HK1245158A1 (zh) 阿吡莫德組合物及其使用方法
IL259203B (en) Hemostatic drug
GB201518379D0 (en) Analytical method and composition
HK1258371A1 (zh) 止血組合物和使用止血組合物的止血方法
GB201520255D0 (en) Composition and method
GB2550632B (en) Compositions and uses and methods relating thereto
SG11201707046XA (en) Gel composition and method for manufacturing same
GB201700116D0 (en) Method and composition
EP3349748A4 (en) COMPOSITION AND METHOD THEREFOR
GB201502983D0 (en) Composition and process
GB201509420D0 (en) Composition and method
GB201512996D0 (en) Compositions and methods
ZA201904187B (en) Method and composition
GB201703975D0 (en) Composition and methods
GB201513492D0 (en) Method and composition
GB201514413D0 (en) Compositions and methods
GB201714238D0 (en) Composition and method
IL256261B (en) Hide1 compositions and methods
GB201611189D0 (en) Method and composition